Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jul;37(7):1293-1296.
doi: 10.1007/s00345-019-02691-0. Epub 2019 Feb 25.

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?

Keong Tatt Foo  1
Affiliations
Review

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?

Keong Tatt Foo. World J Urol. 2019 Jul.

Abstract

Introduction: Though clinical benign prostatic hyperplasia (BPH) is a common disease worldwide, there is still much confusion in the literature and the many clinical guidelines as to its definition. Often the disease is associated with lower urinary tract symptoms (LUTS) and managed according to only symptoms. This leads to undertreatment in some patients with severe bladder outlet obstruction (BOO) with no symptoms, and overtreatment in patients with LUTS but no clinical BPH.

Definition of a disease: Fundamentally, a disease can be defined as an abnormal structure or function or a condition which may cause harm to the organism.

Definition of clinical bph: Thus, clinical BPH can be defined as prostate adenoma/adenomata, causing a varying degree of BOO, which may eventually cause harm to the patients. With this definition, we are then able to differentiate the disease clinical BPH from the many other less common causes of LUTS, and then treat it according to its severity.

Diagnosing clinical bph: Clinical BPH can be diagnosed with non-invasive ultrasound in the clinic, grading it according to the shape (intravesical prostatic protrusion) and size of the prostate.

Clinical significance: Treatment can then be planned according to the disease severity using our staging system that classifies severity according to the presence or absence of significant obstruction and bothersomeness of symptoms.

Conclusion: This would lead to better individualised and cost-effective management of the disease clinical BPH.

Keywords: Benign prostatic hyperplasia; Definition; Grading; Individualised care; Staging; Transabdominal ultrasound.

PubMed Disclaimer

Conflict of interest statement

The author declares that he has no conflict of interest.

References

    1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-Committee of the International Continence Society The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61(1):37–49. doi: 10.1016/S0090-4295(02)02243-4. - DOI - PubMed
    1. Hirayama A, Samma S, Fujimoto K, Yamaguchi A, Akiyama T, Fukui Y. Comparison of parameters to determine the cause of urinary disturbance in men with prostate volume less than 20 milliliters. Int J Urol. 2002;9(10):554–559. doi: 10.1046/j.1442-2042.2002.00524.x. - DOI - PubMed
    1. Gratzke C, Bachmann A, Descazeaud A, Drake MJ, Madersbacher S, Mamoulakis C, Oelke M, Tikkinen KAO, Gravas S. EAU guidelines on the assessment of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2015;67(6):1099–1109. doi: 10.1016/j.eururo.2014.12.038. - DOI - PubMed
    1. Foo KT. Pathophysiology of clinical benign prostatic hyperplasia. Asian J Urol. 2017;4(3):152–157. doi: 10.1016/j.ajur.2017.06.003. - DOI - PMC - PubMed
    1. Luo GC, Foo KT, Kuo T, Tan G. Diagnosis of prostate adenoma and the relationship between the site of prostate adenoma and bladder outlet obstruction. Singap Med J. 2013;54(9):482–486. doi: 10.11622/smedj.2013168. - DOI - PubMed

MeSH terms